Neuropathy in HIV infection.

Area of Science:

• Neurology
• Infectious Diseases
• Pharmacology

Background:

• Peripheral nerve complications are common in patients with human immunodeficiency virus (HIV).
• These complications can stem from the HIV infection itself or from antiretroviral therapies, specifically zalcitabine, didanosine, or stavudine.
• Differentiating the cause through clinical or neurophysiological methods can be challenging.

Purpose of the Study:

• To review current understanding of peripheral nerve complications in HIV patients.
• To explore therapeutic strategies for managing these complications.
• To highlight recent advancements in nerve function improvement.

Main Methods:

• Literature review of studies on HIV-associated peripheral neuropathy.
• Analysis of symptomatic treatment approaches.
• Examination of novel treatments targeting nerve regeneration and viral load reduction.

Main Results:

• Peripheral neuropathy is a significant source of morbidity in HIV-infected individuals.
• Distinguishing between viral and drug-induced neuropathy is clinically difficult.
• Emerging treatments include recombinant human nerve growth factor and optimized antiretroviral therapy to lower HIV viral load.

Conclusions:

• Peripheral nerve complications represent a major clinical challenge in HIV management.
• Symptomatic treatments have been explored, but focus is shifting towards disease-modifying therapies.
• Nerve growth factors and viral load suppression show promise for improving nerve function in HIV patients.